These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32019779)

  • 21. Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme.
    Lee M; Park C; Woo J; Kim J; Kho I; Nam DH; Park WY; Kim YS; Kong DS; Lee HW; Kim TJ
    Front Immunol; 2019; 10():555. PubMed ID: 30967876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion and immunological study of human tumor infiltrating gamma/delta T lymphocytes in vitro.
    Yu S; He W; Chen J; Zhang F; Ba D
    Int Arch Allergy Immunol; 1999 May; 119(1):31-7. PubMed ID: 10341318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.
    Beck BH; Kim HG; Kim H; Samuel S; Liu Z; Shrestha R; Haines H; Zinn K; Lopez RD
    Breast Cancer Res Treat; 2010 Jul; 122(1):135-44. PubMed ID: 19763820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.
    Mirzaei HR; Mirzaei H; Lee SY; Hadjati J; Till BG
    Cancer Lett; 2016 Oct; 380(2):413-423. PubMed ID: 27392648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
    Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor.
    Deniger DC; Switzer K; Mi T; Maiti S; Hurton L; Singh H; Huls H; Olivares S; Lee DA; Champlin RE; Cooper LJ
    Mol Ther; 2013 Mar; 21(3):638-47. PubMed ID: 23295945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals.
    Ryan PL; Sumaria N; Holland CJ; Bradford CM; Izotova N; Grandjean CL; Jawad AS; Bergmeier LA; Pennington DJ
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14378-14383. PubMed ID: 27911793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy.
    Abe Y; Kobayashi H; Akizawa Y; Ishitani K; Hashimoto K; Matsui H
    Anticancer Res; 2018 Jul; 38(7):4327-4331. PubMed ID: 29970569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
    Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
    Front Immunol; 2020; 11():1287. PubMed ID: 32636849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
    Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
    World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.
    Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L
    Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage.
    Lo Presti E; Toia F; Oieni S; Buccheri S; Turdo A; Mangiapane LR; Campisi G; Caputo V; Todaro M; Stassi G; Cordova A; Moschella F; Rinaldi G; Meraviglia S; Dieli F
    Cancer Immunol Res; 2017 May; 5(5):397-407. PubMed ID: 28351891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
    Chen J; Niu H; He W; Ba D
    Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
    Gomes AQ; Martins DS; Silva-Santos B
    Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4
    Lu J; Huang C; He R; Xie R; Li Y; Guo X; Zhang Q; Xu Q
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9007-9016. PubMed ID: 37165118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic CD69
    Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.
    Chabab G; Barjon C; Abdellaoui N; Salvador-Prince L; Dejou C; Michaud HA; Boissière-Michot F; Lopez-Crapez E; Jacot W; Pourquier D; Bonnefoy N; Lafont V
    J Leukoc Biol; 2020 Jun; 107(6):1057-1067. PubMed ID: 32362028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-Cell RNAseq Profiling of Human γδ T Lymphocytes in Virus-Related Cancers and COVID-19 Disease.
    Cerapio JP; Perrier M; Pont F; Tosolini M; Laurent C; Bertani S; Fournie JJ
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.